The TL1A inhibitor market is rapidly advancing, driven by significant investments from major biopharmaceutical companies and growing confidence in its potential to transform autoimmune disease management, particularly in IBD. Leading mid- to late-stage candidates, such […]
The prurigo nodularis treatment landscape has been evolving in recent years, with increasing attention from the pharmaceutical industry due to the chronic and debilitating nature of the condition. There is growing recognition of the need […]
RADNOR, Pa., April 11, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Quantum Computing Inc. (“QCI”) (NASDAQ: QUBT) […]
RADNOR, Pa., March 2, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Venture Global, Inc. (“Venture”) (NYSE: VG) on […]
RADNOR, Pa., March 2, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Grocery Outlet Holding Corp. (“Grocery Outlet”) (NASDAQ: […]
